7-year sustained efficacy, safety, and immunological improvement with fostemsavirbased regimens in individuals with HIV-1 and limited treatment options

Authors
Category Primary study
Conference6th Joint Conference of the British HIV Association, BHIVA and the British Association for Sexual Health and HIV, BASHH
Year 2026
This article has no abstract
Epistemonikos ID: baf9a6ae83c795f80333dcad264da6eb725fa5d6
First added on: Jul 04, 2026